Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Solid Biosciences (SLDB) Interest & Investment Income: 2017-2024

Historic Interest & Investment Income for Solid Biosciences (SLDB) over the last 7 years, with Dec 2024 value amounting to $1.9 million.

  • Solid Biosciences' Interest & Investment Income rose 9.38% to $1.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $9.5 million, marking a year-over-year increase of 24.90%. This contributed to the annual value of $9.5 million for FY2024, which is 24.89% up from last year.
  • Latest data reveals that Solid Biosciences reported Interest & Investment Income of $1.9 million as of Q4 2024, which was down 17.31% from $2.3 million recorded in Q3 2024.
  • Solid Biosciences' 5-year Interest & Investment Income high stood at $2.7 million for Q1 2024, and its period low was -$20,000 during Q3 2020.
  • For the 3-year period, Solid Biosciences' Interest & Investment Income averaged around $1.8 million, with its median value being $1.9 million (2024).
  • Per our database at Business Quant, Solid Biosciences' Interest & Investment Income tumbled by 105.35% in 2020 and then surged by 3,714.81% in 2023.
  • Solid Biosciences' Interest & Investment Income (Quarterly) stood at -$16,000 in 2020, then reached $1.5 million in 2022, then rose by 14.73% to $1.8 million in 2023, then increased by 9.38% to $1.9 million in 2024.
  • Its Interest & Investment Income stands at $1.9 million for Q4 2024, versus $2.3 million for Q3 2024 and $2.6 million for Q2 2024.